A
clinical trial published in The Lancet, a top medical journal, shows
that an intensive procedure that completely wipes out the immune system
and then regenerates a new one using blood stem cells can eliminate all
signs of damaging brain inflammation in people with early, aggressive
multiple sclerosis (MS), and facilitate lasting recovery.
This
treatment was talked about over 10 years ago... But a
number of participants in the early trials died so early enthusiasm
waned for awhile. Instead much attention and millions of dollars went into studying the CCSVI which turned out to be not for everyone.
Chronic cerebrospinal venous insufficiency (CCSVI)
Research findings to date indicate there is no
connection between CCSVI and MS.
A growing body of evidence on the prevalence of CCSVI among people
living with MS suggest that CCSVI is not linked with MS. Researchers suggest
that discrepancies in results may be attributed to inconsistencies in imaging
techniques, training of personnel, and interpretation of results. As well, some
studies challenge the validity of the proposed diagnostic criteria for CCSVI.
***********************************************************************************************
News Release
MS breakthrough: Replacing diseased immune system halts progression and allows repair
June 9, 2016
Led by
Dr. Harold Atkins and Dr. Mark S. Freedman of The Ottawa Hospital and
the University of Ottawa, the trial included 24 participants who were
followed for up to 13 years. The $6.47 million trial was funded by the
MS Society of Canada and its affiliated Multiple Sclerosis Scientific
Research Foundation. The research was also supported by The Ottawa
Hospital Foundation, The Ottawa Hospital Department of Medicine and
Canadian Blood Services.
Lean more here: http://bit.ly/1PcBTuO
Lean more here: http://bit.ly/1PcBTuO
No comments:
Post a Comment